These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 4106553)
41. Letter: Safe use of 125I-fibrinogen not proven. Goudie RB; Lindsay MK; Pettigrew NM Lancet; 1973 Nov; 2(7837):1083. PubMed ID: 4127333 [No Abstract] [Full Text] [Related]
42. The frequency and persistence of hepatitis-associated antigen in Calcutta blood donors and a case study of transfusion-associated hepatitis. Graves IL; Biswas SK Indian J Med Res; 1974 Mar; 62(3):384-93. PubMed ID: 4452587 [No Abstract] [Full Text] [Related]
43. Australia antigen, posttransfusion hepatitis, and the chronic carrier state. Sutnick AI; London WT; Blumberg BS; Vierucci A Am J Dis Child; 1972 Apr; 123(4):392-400. PubMed ID: 4260367 [No Abstract] [Full Text] [Related]
44. The Ausria test: critical evaluation of sensitivity and specificity. Alter HJ; Holland PV; Purcell RH; Gerin JL Blood; 1973 Dec; 42(6):947-57. PubMed ID: 4202455 [No Abstract] [Full Text] [Related]
45. Antibody against serum-hepatitis antigen. Prevalence and potential use as immune serum globulin in prevention of serum-hepatitis infections. Prince AM; Szmuness W; Woods KR; Grady GF N Engl J Med; 1971 Oct; 285(17):933-8. PubMed ID: 4106379 [No Abstract] [Full Text] [Related]
46. [Hepatitis among drug abusers--an epidemiologic problem]. Lund BM; Ellekjaer EF; Holst-Larsen L Tidsskr Nor Laegeforen; 1973 Sep; 93(25):1768-9. PubMed ID: 4129546 [No Abstract] [Full Text] [Related]
47. [Post-transfusion hepatitis. Effects of long-term screening for HBsAg carriers among blood donors]. Pintera J Cas Lek Cesk; 1982 Sep; 121(37):1148-52. PubMed ID: 7139671 [No Abstract] [Full Text] [Related]
48. [Post-transfusion hepatitis and the diagnosis of infectious hepatitis in donors (a review of the literature and the authors' own data)]. Gromashevskaia LL; Khersonskaia RIa; Stroganov BV Probl Gematol Pereliv Krovi; 1973 Feb; 18(2):40-5. PubMed ID: 4587776 [No Abstract] [Full Text] [Related]
50. Hepatitis B immune serum globulin in prevention of nonparenterally transmitted hepatitis B. Szmuness W; Prince AM; Goodman M; Ehrich C; Pick R; Ansari M N Engl J Med; 1974 Mar; 290(13):701-6. PubMed ID: 4130658 [No Abstract] [Full Text] [Related]
51. Blood bank service screening of Australia antigen and antibodies at Mainz, Germany. Arndt-Hanser A; Pyka R Vox Sang; 1973; 24():Suppl:72-5. PubMed ID: 4198173 [No Abstract] [Full Text] [Related]
52. Is transfusion hepatitis here to stay? Grady G N Engl J Med; 1973 Aug; 289(8):425-6. PubMed ID: 4719830 [No Abstract] [Full Text] [Related]
54. Australia antigen and post transfusion hepatitis. Berthold H; Kleine N; Büttner G; Müller G Prog Immunobiol Stand; 1971; 5():63-6. PubMed ID: 4633979 [No Abstract] [Full Text] [Related]
55. Active and passive immunization of viral hepatitis. Ginsberg AL Med Clin North Am; 1975 Jul; 59(4):857-62. PubMed ID: 49465 [No Abstract] [Full Text] [Related]
57. [Hepatitis following blood transfusions]. Busch H; Roos D; Creutzfeldt W Dtsch Med Wochenschr; 1971 Oct; 96(43):1694-6. PubMed ID: 5099201 [No Abstract] [Full Text] [Related]
58. [The epidemiologic role of donors who are long-term carriers of the Australian antigen]. Golosova TV; Kasavina MA; Margolina AN; Kantorovich RA Zh Mikrobiol Epidemiol Immunobiol; 1974 Jan; (1):102-5. PubMed ID: 4454805 [No Abstract] [Full Text] [Related]
59. Australia antigen. Progress report. Sutnick AI Med Clin North Am; 1973 Jul; 57(4):1029-43. PubMed ID: 4123112 [No Abstract] [Full Text] [Related]
60. [Prevention of hepatitis B in hospital practice]. Gota F; Lombardi A Arch Sci Med (Torino); 1979; 136(4):585-9. PubMed ID: 95159 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]